Idexx Laboratories Inc /De IDXX

Revenue Intelligence Report • 66 quarters of SEC filing data • Updated 2026-03-15

Idexx Laboratories Inc /De has a forecasted full-year revenue of $4.6B, a +6.9% year-over-year change, based on 66 quarters of SEC filing data. Key revenue drivers include SG&A ($1.10 per $1). The ARDL model achieves strong accuracy at 2.7% MAPE.

Investment Thesis

Our ARDL model tracks Idexx Laboratories Inc /De's revenue with exceptional precision (2.7% MAPE), indicating highly predictable cash flows. Each $1 of SG&A spending generates $1.10 in revenue, reflecting strong commercial efficiency.

Next FY Revenue
$4.60B
+6.9% YoY
R&D Multiplier
$-5.90 per $1
SG&A Multiplier
$1.10 per $1
Model Accuracy
2.7% MAPE
Holdout validation: The model predicted $1.1B vs the actual $1.1B — an error of 1.5%.
⚠ Model limitation: This company shows negative spending multipliers, meaning increases in spending have not directly translated into revenue growth. This typically occurs with commodity-driven companies or hypergrowth companies.

Revenue Forecast

IDXX Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q4 2025 $1.1B $1.1B $1.0B – $1.1B +12.5% ✓ In range
Q2 2026 $1.1B $1.0B – $1.1B +9.1%
Q3 2026 $1.2B $1.1B – $1.2B +3.7%
Q4 2026 $1.2B $1.1B – $1.3B +6.9%
Q1 2027 $1.2B $1.1B – $1.3B +8.0%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Idexx Laboratories Inc /De's systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.
Fiscal QuarterSeasonal Factorvs TrendInterpretationObs.
FQ1 (Sep–Nov) 0.9686 -3.1% -3.1% below trend 16
FQ2 (Dec–Feb) 0.9972 -0.3% In line with trend 16
FQ3 (Mar–May) 0.9973 -0.3% In line with trend 15
FQ4 (Jun–Aug) 1.0272 +2.7% In line with trend 15

How Spending Drives Revenue

IDXX Spending Timing
Reading this chart: Each line shows the cumulative revenue generated per $1 spent over subsequent quarters. The effect builds over 4-5 quarters as investments mature.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

More in Healthcare

CAH REGN BIIB VTRS KVUE CI MRK ELV